Home
Resources
Diseases
COVID-19
Ebola
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hepatitis B birth dose vaccines
Hexavalent vaccines
HPV vaccines
Malaria vaccines
Measles containing vaccines
PCV vaccines
RSV vaccines
Typhoid Conjugate Vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (43)
NITAG documentation (1644)
Reports (65)
SAGE documentation (227)
Scientific publications (124)
Systematic reviews (SYSVAC) (3220)
Regions
Africa (301)
Americas (797)
Eastern Mediterranean (61)
Europe (754)
Global (1)
South-East Asia (91)
Western Pacific (219)
Diseases
Chikungunya (13)
Cholera (35)
COVID-19 (1611)
Cytomegalovirus (1)
Dengue (46)
Diphtheria (94)
Ebola (21)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (75)
Hepatitis A (72)
Hepatitis B (178)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (81)
HIV / AIDS (10)
Human papillomavirus (HPV) (556)
Influenza (649)
Japanese encephalitis (36)
Lyme disease, Borreliosis (2)
Malaria (35)
Measles (155)
Meningococcal disease (159)
Moraxella catarrhalis (1)
Mpox (59)
Mumps (57)
Pertussis (125)
Pneumococcal disease (315)
Poliomyelitis (100)
Q fever (1)
Rabies (34)
Rotavirus (124)
RSV (Respiratory syncytial virus) (73)
Rubella (77)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (75)
Tick-borne encephalitis (14)
Tuberculosis (86)
Typhoid (33)
Varicella (82)
Yellow fever (47)
Zika (2)
Show more
5323 results found
2003
∙
ACIP
Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program
2003
∙
ACIP
Smallpox Vaccination and Adverse Reactions
2003
∙
ACIP
Supplemental Recommendations on Adverse Events Following Smallpox Vaccine in the Pre-Event Vaccination Program
2002
∙
ACIP
Adverse Events Associated with 17D-Derived Yellow Fever Vaccination
2002
Food and Drug Administration Approval of a Fifth Acellular Pertussis Vaccine for Use Among Infants and Young Children
2002
∙
ACIP
Pneumococcal Vaccination for Cochlear Implant Recipients
2002
∙
ACIP
Pneumococcal Vaccination for Cochlear Implant Recipients
2002
∙
Jean Faber
Recommendation on the Treatment of Latent Tuberculosis Infection
2002
∙
ACIP
Yellow Fever Vaccine Recommendations
2001
∙
ACIP
FDA Approval for a Combined Hepatitis A and B Vaccine
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
